A comprehensive view of hospital/clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly reports Indiana’s new restrictive abortion law could hinder its ability to attract diverse scientific, engineering, business talent to the state; Lilly planning for more employment growth outside of Indiana

United Therapeutics reports Q2 net income down at US$116.0M from US$172.6M a year ago, with total revenue up 5% year-over-year to US$466.9M; Q2 sales of treprostinil-based products grew US$42.2M compared to a year ago

Biogen’s staff count at Cambridge, Massachusetts, site drops by 301 employees since first of the year reports Boston Business Journal; Biogen to lay off as many as 1,000 employees in US$1B cost-cutting plan due to failure of Aduhelm Alzheimer’s drug

Jury orders Eli Lilly to pay over US$61.0M in damages in whistleblower lawsuit alleging Lilly underpaid Medicaid drug rebates; False Claims Act allows damages to be tripled, with final judgement possibly to be more than US$183.0M

Amgen reports Q2 net income up at US$1.3B from US$464.0M a year ago, with total revenues up 1% to US$6.6B; results driven by 3% growth in global product sales, double-digit growth in a number of products including Repatha, Prolia, Evenity

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count